Young Hoon Kim
Other affiliations: St Mary's Hospital
Bio: Young Hoon Kim is an academic researcher from Catholic University of Korea. The author has contributed to research in topics: Medicine & Sagittal plane. The author has an hindex of 41, co-authored 444 publications receiving 6355 citations. Previous affiliations of Young Hoon Kim include St Mary's Hospital.
Papers published on a yearly basis
TL;DR: MR imaging showed higher per-lesion sensitivity than multidetector CT and should be the preferred imaging modality for the diagnosis of HCCs in patients with chronic liver disease.
Abstract: For the diagnosis of hepatocellular carcinoma in patients with chronic liver disease, MR imaging has comparable per-patient sensitivity and higher per-lesion sensitivity than CT; MR imaging also showed significantly higher sensitivity for lesions smaller than 1 cm, for lesions in explanted livers, and for all lesions when gadoxetic acid was used.
TL;DR: Low-doseCT was noninferior to standard-dose CT with respect to negative appendectomy rates in young adults with suspected appendicitis, and the percentage of negative appendectomies among all nonincidental appendectoms was 5.5 percentage points.
Abstract: Background Computed tomography (CT) has become the predominant test for diagnosing acute appendicitis in adults. In children and young adults, exposure to CT radiation is of particular concern. We evaluated the rate of negative (unnecessary) appendectomy after low-dose versus standard-dose abdominal CT in young adults with suspected appendicitis. Methods In this single-institution, single-blind, noninferiority trial, we randomly assigned 891 patients with suspected appendicitis to either low-dose CT (444 patients) or standard-dose CT (447 patients). The median radiation dose in terms of dose–length product was 116 mGy·cm in the low-dose group and 521 mGy·cm in the standard-dose group. The primary end point was the percentage of negative appendectomies among all nonincidental appendectomies, with a noninferiority margin of 5.5 percentage points. Secondary end points included the appendiceal perforation rate and the proportion of patients with suspected appendicitis who required additional imaging. Results ...
TL;DR: Annotation error in the title of the paper, where the word “Diodes” was incorrectly given as “Didoes”, has been corrected.
Abstract: Scientific Reports 6: Article number: 24205; published online: 06 April 2016; updated: 20 June 2016 The original version of this Article contained an error in the title of the paper, where the word “Diodes” was incorrectly given as “Didoes”. This error has now been corrected in the PDF and HTML versions of the Article.
TL;DR: Pancreatic fat can be quantified by using CT, and CT attenuation indexes that are applied to the quantification of pancreatic fat are significantly associated with clinical assessment of impaired glucose metabolism.
Abstract: CT attenuation indexes are well correlated with histologically measured pancreatic fat, and they are significantly associated with impaired glucose metabolism.
TL;DR: The authors prospectively treated 10 consecutive patients with multiloculated empyemas with intracavitary instillation of urokinase via a percutaneous drainage catheter to demonstrate any fibrinolytic action and found one patient showed complete drainage of multilocity empyema, but recurrentEmpyema appeared in the site of a previous tube thoracostomy.
Abstract: The authors prospectively treated 10 consecutive patients with multiloculated empyemas with intracavitary instillation of urokinase via a percutaneous drainage catheter. Urokinase (100,000 IU) in 100 mL of 5% dextrose in water was instilled into the pleural cavity via a percutaneous drainage catheter. After overnight clamping, the catheter was opened and the empyema drained with use of negative suction (20 cm H2O). Intermittent irrigation of the catheter with normal saline was performed to prevent clogging of the catheter. Complete drainage of multiloculated empyemas was accomplished in nine patients by means of intracavitary instillation of urokinase via a single 8-F catheter. One patient showed complete drainage of multiloculated empyema, but recurrent empyema appeared in the site of a previous tube thoracostomy. A total of 100,000-700,000 IU (mean, 400,000 IU) of urokinase were needed for complete drainage in all patients. Plasminogen and fibrin degradation product levels in empyema fluid were determin...
28 Jul 2005
TL;DR: The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.
Abstract: Summary Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.
TL;DR: The 11th edition of Harrison's Principles of Internal Medicine welcomes Anthony Fauci to its editorial staff, in addition to more than 85 new contributors.
Abstract: The 11th edition of Harrison's Principles of Internal Medicine welcomes Anthony Fauci to its editorial staff, in addition to more than 85 new contributors. While the organization of the book is similar to previous editions, major emphasis has been placed on disorders that affect multiple organ systems. Important advances in genetics, immunology, and oncology are emphasized. Many chapters of the book have been rewritten and describe major advances in internal medicine. Subjects that received only a paragraph or two of attention in previous editions are now covered in entire chapters. Among the chapters that have been extensively revised are the chapters on infections in the compromised host, on skin rashes in infections, on many of the viral infections, including cytomegalovirus and Epstein-Barr virus, on sexually transmitted diseases, on diabetes mellitus, on disorders of bone and mineral metabolism, and on lymphadenopathy and splenomegaly. The major revisions in these chapters and many
University of Texas MD Anderson Cancer Center1, Oregon Health & Science University2, Mount Sinai St. Luke's and Mount Sinai Roosevelt3, American Cancer Society4, Veterans Health Administration5, Emory University6, Johns Hopkins University School of Medicine7, University of Pennsylvania8, Eastern Virginia Medical School9, Mayo Clinic10, Kaiser Permanente11, University of Wisconsin-Madison12, Indiana University – Purdue University Indianapolis13, Creighton University14, Memorial Sloan Kettering Cancer Center15
TL;DR: Clinicians should be prepared to offer patients a choice between a screening test that is effective at both early cancer detection and cancer prevention through the detection and removal of polyps and those that can detect cancer early and also can detect adenomatous polyps.
Abstract: In the United States, colorectal cancer (CRC) is the third most common cancer diagnosed among men and women and the second leading cause of death from cancer. CRC largely can be prevented by the detection and removal of adenomatous polyps, and survival is significantly better when CRC is diagnosed while still localized. In 2006 to 2007, the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology came together to develop consensus guidelines for the detection of adenomatous polyps and CRC in asymptomatic average-risk adults. In this update of each organization's guidelines, screening tests are grouped into those that primarily detect cancer early and those that can detect cancer early and also can detect adenomatous polyps, thus providing a greater potential for prevention through polypectomy. When possible, clinicians should make patients aware of the full range of screening options, but at a minimum they should be prepared to offer patients a choice between a screening test that primarily is effective at early cancer detection and a screening test that is effective at both early cancer detection and cancer prevention through the detection and removal of polyps. It is the strong opinion of these 3 organizations that colon cancer prevention should be the primary goal of screening.